BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 88755)

  • 1. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants.
    Wank R; Schendel DJ; Blanco ME; Dupont B
    Scand J Immunol; 1979; 9(6):499-505. PubMed ID: 88755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity of secondary MLC assayed by titration of primed lymphocyte populations.
    Singal DP
    Tissue Antigens; 1979 Jul; 14(1):22-31. PubMed ID: 91217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous mixed lymphocyte culture reactivity between HLA--A, --B, --C, --DR identical siblings.
    Reinsmoen NL; Noreen HJ; Friend PS; Giblett ER; Greenberg LJ; Kersey JH
    Tissue Antigens; 1979 Jan; 13(1):19-34. PubMed ID: 154195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of human lymphocyte responses by primed autologous lymphocytes. I. Evaluation of MLR inhibition as a model for suppression.
    Sheehy MJ; Mawas C; Charmot D
    J Immunol; 1979 Jun; 122(6):2198-203. PubMed ID: 87456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typing for MLC determinants: methods and applications.
    Thomsen M; Ryder LP; Svejgaard A
    Scand J Immunol; 1976 Jun; Suppl 5():157-74. PubMed ID: 79216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexity of the HLA-D region studied by primed-lymphocyte test.
    Segall M; Reinsmoen NL; Noreen HJ; Bach FH
    J Exp Med; 1980 Aug; 152(2 Pt 2):156s-163s. PubMed ID: 6157765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limiting dilution analysis of alloantigen-reactive cells which respond to allogeneic lymphocytes in human MLC and PLT.
    Singal DP; Naipaul N; Joseph S
    Tissue Antigens; 1980 Oct; 16(4):274-85. PubMed ID: 6451052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of paternal and maternal HLA-B/D recombinants in a single family.
    Hsu SH; Pollard MK; Bias WB
    Hum Immunol; 1980 Dec; 1(4):325-30. PubMed ID: 6455396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of cell-mediated lympholysis in man.
    Geha RS; Malakian A; Geha O; Yunis E
    J Immunol; 1977 Apr; 118(4):1286-91. PubMed ID: 66285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immune responses to hapten-conjugated cells. II. The roles of autologous and allogeneic histocompatibility determinants in proliferative responses in vitro.
    Seldin MF; Rich RR; Dupont B
    J Immunol; 1979 May; 122(5):1828-33. PubMed ID: 87444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split of HLA-D into two regions alpha and beta by a recombination between HLA-D and GLO. I. Study in a family and primed lymphocyte typing for determinants coded by the beta region.
    Mawas C; Charmot D; Mercier P
    Tissue Antigens; 1980 May; 15(5):458-66. PubMed ID: 6160646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactive T cells: expression of HLA-D antigens, stimulation of autologous MLR, and possible immunoregulatory function.
    Suciu-Foca N; Rohowsky C; Coburn C; Reed E; Khan R; Lewison A
    Hum Immunol; 1981 Dec; 3(4):301-12. PubMed ID: 6460016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restimulation in secondary MLC by autologous non-T cells.
    Zier KS; Huber C; Braunsteiner H
    Scand J Immunol; 1979; 9(6):493-8. PubMed ID: 156946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of HLA-haplotype-specific human T-lymphocyte clones.
    Schendel DJ; Wank R
    Immunobiology; 1981; 160(3-4):367-71. PubMed ID: 6173310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of human lymphocytes primed against allogeneic cells in vitro. 1. Optimalization of culture conditions for detection of HLA--D specificity.
    Moen T; Thorsby E
    Tissue Antigens; 1978 Nov; 12(5):367-80. PubMed ID: 85352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell alloantigens in two recombinant families: prediction of a B/D recombination using B-cell-specific alloantisera.
    Décary F; van Helden-Henningheim L; Westera A; van den Berg-Loonen PM; Engelfriet CP
    Tissue Antigens; 1979 Jan; 13(1):11-8. PubMed ID: 84413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human mixed lymphocyte culture stimulation by anti-HLA-D-associated antisera: studies with primed responding cells.
    Hirschberg H; Albrechtsen D; Solheim BG; Thorsby E
    Eur J Immunol; 1977 Jan; 7(1):26-9. PubMed ID: 139314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LB-Q1 and LB-Q2: two determinants defined in the primed lymphocyte test and independent of HLA-D/DR, MB/LB-E, or SB.
    Termijtelen A; van den Berge SJ; van Rood JJ
    Hum Immunol; 1983 Sep; 8(1):11-5. PubMed ID: 6195131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional cell mediated lympholysis: II. Genetics.
    Goeken NE; Thompson JS
    Tissue Antigens; 1981; 17(4):411-20. PubMed ID: 6949337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.